Fosfomycin for Extended-Spectrum Beta-Lactamase Producers—Initial Monotherapy, Transition Therapy, Combination Therapy or Not at All?

Unresolved referenced work

2012

Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial

10.1001/jama.2018.3627 · 2018

Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial

10.1016/s0140-6736(25)02171-3 · 2026

Clinical practice guideline by Infectious Diseases Society of America: 2025 guideline on management and treatment of complicated urinary tract infections–selection of antibiotic therapy for complicated urinary tract infections

10.1093/cid/ciaf460 · 2026

Daily fosfomycin versus levofloxacin for complicated urinary tract infections

10.1128/mbio.01677-23 · 2023

Fosfomycin as oral transition therapy versus continued intravenous β-lactams for complicated urinary tract infections caused by extended-spectrum β-lactamase producing Enterobacterales: a multicenter, open-label, randomized controlled trial

10.1093/cid/ciag345 · 2026

Fosfomycin vs ciprofloxacin as oral step-down treatment for Escherichia coli febrile urinary tract infections in women: a randomized, placebo-controlled, double-blind, multicenter trial

10.1093/cid/ciab934 · 2022